{"id":92989,"date":"2018-08-29T08:59:49","date_gmt":"2018-08-29T06:59:49","guid":{"rendered":"https:\/\/clinical.r-biopharm.com\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/"},"modified":"2019-05-09T09:38:10","modified_gmt":"2019-05-09T07:38:10","slug":"jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring","status":"publish","type":"post","link":"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/","title":{"rendered":"Jetzt verf\u00fcgbar: Das Komplettpaket f\u00fcr das therapeutische Medikamenten-Monitoring"},"content":{"rendered":"<div class=\"wpb-content-wrapper\">[vc_row][vc_column][vc_column_text css=&#8220;.vc_custom_1557387466757{margin-bottom: 0px !important;}&#8220;]<strong>Chronisch entz\u00fcndliche Erkrankungen wie Morbus Crohn, Colitis ulcerosa oder Rheuma k\u00f6nnen mit den TNF\u03b1-Blockern Infliximab und Adalimumab gut behandelt werden. Damit \u00dcber- und Unterdosierungen vermieden werden und die Therapie langfristig erfolgreich ist, ist es sinnvoll, die Wirkstoffkonzentration im Blut zu \u00fcberwachen. Daf\u00fcr bietet R-Biopharm ein umfangreiches Angebot.<\/strong><!--more--><\/p>\n<p>Der neue Adalimumab-Schnelltest RIDA\u00aeQUICK ADM Monitoring erweitert das Produktportfolio im Bereich therapeutisches Medikamenten-Monitoring (TDM). Mit der Auswahl an Schnelltests und ELISA-Tests sind sowohl Arztpraxen als auch Labore optimal aufgestellt. Alle Testsysteme enthalten gebrauchsfertige Reagenzien und sind durch die KU Leuven (Belgien) validiert.<\/p>\n<p>F\u00fcr das schnelle Monitoring direkt in der Praxis eignen sich immunchromatographische <a href=\"https:\/\/clinical.r-biopharm.com\/de\/technologien\/schnelltests\/\">Lateral-Flow-Tests<\/a>. Die Schnelltests von R-Biopharm bestimmen die Talspiegel in nur 20 Minuten und erlauben so eine unmittelbare Dosisanpassung. Sie sind verf\u00fcgbar f\u00fcr die Messung von Infliximab und dessen Biosimilars sowie f\u00fcr Adalimumab. Die Durchf\u00fchrung ist sehr einfach und erfordert nur wenig Laborausstattung, wie das folgende Video zeigt.[\/vc_column_text][vc_video link=&#8220;https:\/\/www.youtube.com\/watch?v=CwFDl2L9NN4&#8243;][vc_empty_space][vc_column_text css=&#8220;.vc_custom_1557387487707{margin-bottom: 0px !important;}&#8220;]Effiziente Analysen auch bei hohem Probenaufkommen erm\u00f6glichen <a href=\"https:\/\/clinical.r-biopharm.com\/de\/technologien\/elisa\/\">ELISA-Tests<\/a>. Die Analysen k\u00f6nnen mittels ELISA-Ger\u00e4ten (z.B. DSX\u00ae) auch automatisiert durchgef\u00fchrt werden. Das Portfolio f\u00fcr \u00a0therapeutisches Medikamenten-Monitoring umfasst Tests zur Bestimmung von Infliximab, Adalimumab und Vedolizumab. In manchen F\u00e4llen bildet der Patient Antik\u00f6rper gegen das Medikament, die die Wirkung neutralisieren. Bei sehr niedrigen Talspiegelkonzentrationen sollte das Blut daher auf Anti-Drug-Antik\u00f6rper getestet werden, um zu ermitteln, ob eine Anpassung der Therapie n\u00f6tig ist. Auch hierf\u00fcr sind entsprechende Tests verf\u00fcgbar.<\/p>\n<p>Unser Portfolio auf einen Blick:[\/vc_column_text][vc_single_image image=&#8220;92997&#8243; img_size=&#8220;full&#8220;][vc_cta h2=&#8220;Fragen?&#8220; shape=&#8220;square&#8220; style=&#8220;flat&#8220; add_button=&#8220;right&#8220; btn_title=&#8220;Kontakt&#8220; btn_style=&#8220;flat&#8220; btn_shape=&#8220;square&#8220; btn_color=&#8220;inverse&#8220; btn_link=&#8220;url:mailto%3Ainfo%40r-biopharm.de|&#8220;]Sie m\u00f6chten mehr \u00fcber das therapeutische Medikamentenmonitoring wissen? Unsere Gastroenterologie-Experten helfen Ihnen gerne weiter.[\/vc_cta][\/vc_column][\/vc_row]\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text css=&#8220;.vc_custom_1557387466757{margin-bottom: 0px !important;}&#8220;]Chronisch entz\u00fcndliche Erkrankungen wie Morbus Crohn, Colitis ulcerosa oder Rheuma k\u00f6nnen mit den TNF\u03b1-Blockern Infliximab und Adalimumab gut behandelt werden. Damit \u00dcber- und Unterdosierungen vermieden werden und die Therapie langfristig erfolgreich ist, ist es sinnvoll, die Wirkstoffkonzentration im Blut zu \u00fcberwachen. Daf\u00fcr bietet R-Biopharm ein umfangreiches Angebot.<\/p>\n","protected":false},"author":27,"featured_media":92991,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[239,257,252],"tags":[],"class_list":["post-92989","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gastroenterologie","category-schnelltests","category-therapeutisches-drug-monitoring"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Das Komplettpaket f\u00fcr das therapeutische Medikamenten-Monitoring<\/title>\n<meta name=\"description\" content=\"Chronisch entz\u00fcndliche Erkrankungen k\u00f6nnen mit Infliximab und Adalimumab gut behandelt werden. Medikamentenmonitoring sichert den Therapierfolg.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Das Komplettpaket f\u00fcr das therapeutische Medikamenten-Monitoring\" \/>\n<meta property=\"og:description\" content=\"Chronisch entz\u00fcndliche Erkrankungen k\u00f6nnen mit Infliximab und Adalimumab gut behandelt werden. Medikamentenmonitoring sichert den Therapierfolg.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/\" \/>\n<meta property=\"og:site_name\" content=\"Clinical Diagnostics\" \/>\n<meta property=\"article:published_time\" content=\"2018-08-29T06:59:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-05-09T07:38:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2018\/08\/2018-08_news_website_rq-adm-monitoring_de.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"690\" \/>\n\t<meta property=\"og:image:height\" content=\"252\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Janine Dege\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Janine Dege\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/\"},\"author\":{\"name\":\"Janine Dege\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/7bcf9ead36ba80c48ad551e786874e6f\"},\"headline\":\"Jetzt verf\u00fcgbar: Das Komplettpaket f\u00fcr das therapeutische Medikamenten-Monitoring\",\"datePublished\":\"2018-08-29T06:59:49+00:00\",\"dateModified\":\"2019-05-09T07:38:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/\"},\"wordCount\":359,\"image\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2018\/08\/2018-08_news_website_rq-adm-monitoring_de.jpg\",\"articleSection\":[\"Gastroenterologie\",\"Schnelltests\",\"Therapeutisches Drug Monitoring\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/\",\"url\":\"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/\",\"name\":\"Das Komplettpaket f\u00fcr das therapeutische Medikamenten-Monitoring\",\"isPartOf\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2018\/08\/2018-08_news_website_rq-adm-monitoring_de.jpg\",\"datePublished\":\"2018-08-29T06:59:49+00:00\",\"dateModified\":\"2019-05-09T07:38:10+00:00\",\"author\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/7bcf9ead36ba80c48ad551e786874e6f\"},\"description\":\"Chronisch entz\u00fcndliche Erkrankungen k\u00f6nnen mit Infliximab und Adalimumab gut behandelt werden. Medikamentenmonitoring sichert den Therapierfolg.\",\"breadcrumb\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/#primaryimage\",\"url\":\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2018\/08\/2018-08_news_website_rq-adm-monitoring_de.jpg\",\"contentUrl\":\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2018\/08\/2018-08_news_website_rq-adm-monitoring_de.jpg\",\"width\":690,\"height\":252,\"caption\":\"rida-quick-adm-monitoring\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/clinical.r-biopharm.com\/de\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Jetzt verf\u00fcgbar: Das Komplettpaket f\u00fcr das therapeutische Medikamenten-Monitoring\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/fr\/#website\",\"url\":\"https:\/\/clinical.r-biopharm.com\/fr\/\",\"name\":\"Clinical Diagnostics\",\"description\":\"A Division of the R-Biopharm Group\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/clinical.r-biopharm.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/7bcf9ead36ba80c48ad551e786874e6f\",\"name\":\"Janine Dege\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/4cbca03fc07097934a5058c95fc3b1baaf182a156a174233532f9c3887c50eee?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/4cbca03fc07097934a5058c95fc3b1baaf182a156a174233532f9c3887c50eee?s=96&d=mm&r=g\",\"caption\":\"Janine Dege\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Das Komplettpaket f\u00fcr das therapeutische Medikamenten-Monitoring","description":"Chronisch entz\u00fcndliche Erkrankungen k\u00f6nnen mit Infliximab und Adalimumab gut behandelt werden. Medikamentenmonitoring sichert den Therapierfolg.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/","og_locale":"de_DE","og_type":"article","og_title":"Das Komplettpaket f\u00fcr das therapeutische Medikamenten-Monitoring","og_description":"Chronisch entz\u00fcndliche Erkrankungen k\u00f6nnen mit Infliximab und Adalimumab gut behandelt werden. Medikamentenmonitoring sichert den Therapierfolg.","og_url":"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/","og_site_name":"Clinical Diagnostics","article_published_time":"2018-08-29T06:59:49+00:00","article_modified_time":"2019-05-09T07:38:10+00:00","og_image":[{"width":690,"height":252,"url":"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2018\/08\/2018-08_news_website_rq-adm-monitoring_de.jpg","type":"image\/jpeg"}],"author":"Janine Dege","twitter_misc":{"Verfasst von":"Janine Dege","Gesch\u00e4tzte Lesezeit":"2\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/#article","isPartOf":{"@id":"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/"},"author":{"name":"Janine Dege","@id":"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/7bcf9ead36ba80c48ad551e786874e6f"},"headline":"Jetzt verf\u00fcgbar: Das Komplettpaket f\u00fcr das therapeutische Medikamenten-Monitoring","datePublished":"2018-08-29T06:59:49+00:00","dateModified":"2019-05-09T07:38:10+00:00","mainEntityOfPage":{"@id":"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/"},"wordCount":359,"image":{"@id":"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/#primaryimage"},"thumbnailUrl":"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2018\/08\/2018-08_news_website_rq-adm-monitoring_de.jpg","articleSection":["Gastroenterologie","Schnelltests","Therapeutisches Drug Monitoring"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/","url":"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/","name":"Das Komplettpaket f\u00fcr das therapeutische Medikamenten-Monitoring","isPartOf":{"@id":"https:\/\/clinical.r-biopharm.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/#primaryimage"},"image":{"@id":"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/#primaryimage"},"thumbnailUrl":"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2018\/08\/2018-08_news_website_rq-adm-monitoring_de.jpg","datePublished":"2018-08-29T06:59:49+00:00","dateModified":"2019-05-09T07:38:10+00:00","author":{"@id":"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/7bcf9ead36ba80c48ad551e786874e6f"},"description":"Chronisch entz\u00fcndliche Erkrankungen k\u00f6nnen mit Infliximab und Adalimumab gut behandelt werden. Medikamentenmonitoring sichert den Therapierfolg.","breadcrumb":{"@id":"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/#primaryimage","url":"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2018\/08\/2018-08_news_website_rq-adm-monitoring_de.jpg","contentUrl":"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2018\/08\/2018-08_news_website_rq-adm-monitoring_de.jpg","width":690,"height":252,"caption":"rida-quick-adm-monitoring"},{"@type":"BreadcrumbList","@id":"https:\/\/clinical.r-biopharm.com\/de\/news\/jetzt-verfugbar-das-komplettpaket-fur-das-therapeutische-medikamenten-monitoring\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/clinical.r-biopharm.com\/de\/"},{"@type":"ListItem","position":2,"name":"Jetzt verf\u00fcgbar: Das Komplettpaket f\u00fcr das therapeutische Medikamenten-Monitoring"}]},{"@type":"WebSite","@id":"https:\/\/clinical.r-biopharm.com\/fr\/#website","url":"https:\/\/clinical.r-biopharm.com\/fr\/","name":"Clinical Diagnostics","description":"A Division of the R-Biopharm Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/clinical.r-biopharm.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/7bcf9ead36ba80c48ad551e786874e6f","name":"Janine Dege","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/4cbca03fc07097934a5058c95fc3b1baaf182a156a174233532f9c3887c50eee?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4cbca03fc07097934a5058c95fc3b1baaf182a156a174233532f9c3887c50eee?s=96&d=mm&r=g","caption":"Janine Dege"}}]}},"_links":{"self":[{"href":"https:\/\/clinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/posts\/92989","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/clinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/comments?post=92989"}],"version-history":[{"count":4,"href":"https:\/\/clinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/posts\/92989\/revisions"}],"predecessor-version":[{"id":97054,"href":"https:\/\/clinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/posts\/92989\/revisions\/97054"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/media\/92991"}],"wp:attachment":[{"href":"https:\/\/clinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/media?parent=92989"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/categories?post=92989"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinical.r-biopharm.com\/de\/wp-json\/wp\/v2\/tags?post=92989"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}